This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage

Sponsored by Laniado Hospital

About this trial

Last updated 8 years ago

Study ID

0148-16-LND-2016121

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
1 to 3 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 8 years ago

What is this trial about?

Intraventricular hemorrhage (IVH) is the most commonly recognized cerebral lesion on ultrasound in extremely preterm infants. Papile classification is commonly used to grade the severity of IVH. Grade III-IV IVH and other lesions noted on ultrasound including periventricular leukomalacia (pvl) porencephaly, and ventriculomegaly are well Documented to be associated with adverse neurodevelopmental outcomes. However, the true impact of lower-grade IVH on the neurodevelopment of these extreme preterm infants has not been well described. Also Neurodevelopmental outcome for neonatal non-traumatic Intra Cranial Hemorrhage (ICH) is not well established. The aim of this study is to look retrospectively at babies with neonatal IVH or ICH and follow their radiological, cognitive, motor and functional outcomes. The study will focus on postnatal files, and on images performed as part of the child's follow-up during hospitalization and after discharge.

What are the participation requirements?

Yes

Inclusion Criteria

newborns or premature babies who suffered intra-cranial or intra-ventricular hemorrhage children who are followed by PI in the neurosurgical clinic in Laniado hospital and suffered from ICH or IVH and were treated elsewhere after birth -

No

Exclusion Criteria

loss to followup within the first year after birth -

Locations

Location

Status

Recruiting